A flexible bioluminescent-quantitative polymerase chain reaction assay for analysis of competitive PCR amplicons

Abstract

Aequorin-based flash-type bioluminescent methods can detect nucleic acid molecules in the attomolar range (10-18) enabling improved monitoring of the polymerase chain reaction (PCR) at cycles previously considered too low for product detection. The high sensitivity of bioluminescence (BL) was used to examine the efficiency of the PCR and to assess the effect of substrate variation during the linear phase of amplification. Primer efficiency was dependent on initial template concentration, in a manner indicative of a two-component reaction. However, the rate of amplicon formation was significantly impaired at low template levels and could not be overcome by excess primer. The PCR was directly dependent upon nucleotide concentration, which was independent of template concentration. Conditions were identified for optimal linear amplification and detection using BL. Accurate quantitative analysis was performed using competitive coamplification of a specific target standard sequence containing identical target primer recognition sites and novel internal sequences. Quantitation was most accurate when target molecule was similar in concentration to the internal standard. The Bioluminescent Quantitative-PCR (BLQ-PCR) assay has the potential to eliminate processing variability. We demonstrated high quantitative potential with a broad dynamic range. Overall, the BLQ-PCR assay is flexible and a viable alternative to contemporary Q-PCR techniques.

Ca2+-Regulated Photoproteins: Effective Immunoassay Reporters

“…, higher sensitivity and ability to analyze products in an automated microtiter plate format. Shortly after that, bioluminescent immunoassay in combination with internal standard and competitive coamplification technique [ 39 ] was demonstrated as an accurate tool for DNA and mRNA quantitation in many medico-biological applications: to quantify human immunodeficiency virus (HIV-1) DNA or RNA in plasma, vaginal lavage and cultured cells [ 40 ]; to evaluate efficacy of conventional and DNA vaccinations against Helicobacter pylory [ 41 ]; and to investigate gene expression under infectious disease conditions [ 42 – 46 ].…”